Corton Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,528
Closed -$307K 462
2023
Q1
$307K Sell
4,528
-3,854
-46% -$248K 0.21% 146
2022
Q4
$415K Sell
8,382
-449
-5% -$18.3K 0.34% 81
2022
Q3
$287K Buy
8,831
+1,677
+23% +$69.1K 0.35% 113
2022
Q2
$282K Sell
7,154
-730
-9% -$39K 0.27% 160
2022
Q1
$551K Buy
+7,884
New +$576K 0.24% 95

Other funds holding EXAS

Corton Capital's EXAS Position: Q2 2023 in Review

Corton Capital sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 4,528 shares — an estimated $307K sold.

Corton Capital first reported a position in EXAS in Q1 2022 and held it in 5 quarters. The position peaked at $551K in Q1 2022. 652 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • Corton Capital reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
  • Corton Capital sold 4,528 Exact Sciences shares in Q2 2023, an estimated $307K.
  • Corton Capital first reported a position in Exact Sciences in Q1 2022 and held it in 5 quarters.
  • Corton Capital's Exact Sciences position peaked at $551K in Q1 2022.
  • 652 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Corton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.